The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats

We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, sub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2008-03, Vol.126 (2), p.162-165
Hauptverfasser: Ishida, Tatsuhiro, Kashima, Syuntaro, Kiwada, Hiroshi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 165
container_issue 2
container_start_page 162
container_title Journal of controlled release
container_volume 126
creator Ishida, Tatsuhiro
Kashima, Syuntaro
Kiwada, Hiroshi
description We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, subsequently leading to substantial complement activation and complement-receptor mediated uptake of the second dose by hepatic Kupffer cells. In this study we found, by using a single-pass liver perfusion technique, that the first dose does not increase the intrinsic phagocytic activity of the Kupffer cells. It was also found that only serum obtained from rats that had received a first dose is able to enhance the hepatic uptake of test dose. The conditioned-serum-dependent hepatic uptake was completely abolished by pre-treatment of the serum at 56 °C for 30 min, which inhibits the complement activity. Conclusively, our results strongly support our earlier proposal that complement activation caused by anti-PEG IgM elicited by the first dose is a major cause of the initiation of the accelerated blood clearance of a subsequent dose PEGylated liposome in the ABC phenomenon.
doi_str_mv 10.1016/j.jconrel.2007.11.009
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70292053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365907006323</els_id><sourcerecordid>70292053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-f6d6937f5ef8f4bff81fe3b43c6aee7c96b91b4c9531897e06bae5ec3df283293</originalsourceid><addsrcrecordid>eNqFkcFu3CAYhFHVqNmkfYRWXFqlB7tgbGxOVbJK00iR2kN6Rhj_NKyw2QK70j5FXzl412qPOSAk-Gbgn0HoPSUlJZR_2ZQb7acArqwIaUtKS0LEK7SiXcuKWojmNVplrisYb8Q5uohxQwhpWN2-Qee0o5zQlqzQ38cnwNkoBdvvkvUT9gZvn9Rvrw_Jaqx0snubDvOxs3sIeFQ6-JmAiJPHKeuV1uAgqAQD7p33A9YOVFCTBnx1fbP-nB1h8mNeR_-ft3cHd6Sd3fqYLyK2E84G8S06M8pFeLfsl-jXt9vH9ffi4cfd_fr6odC1IKkwfOCCtaYB05m6N6ajBlhfM80VQKsF7wXtay0aRjvRAuG9ggY0G0zVsUqwS_Tp5LsN_s8OYpKjjXkKpybwuyhbUokqx_UiWFHCGWFtBpsTmOOJMYCR22BHFQ6SEjlXJjdyqUzOlUlKZa4s6z4sD-z6EYb_qqWjDHxcABW1cmbO1cZ_XPbqODmO9PXEQc5tbyHIqC3kDgYbQCc5ePvCV54BTrO59g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21063037</pqid></control><display><type>article</type><title>The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ishida, Tatsuhiro ; Kashima, Syuntaro ; Kiwada, Hiroshi</creator><creatorcontrib>Ishida, Tatsuhiro ; Kashima, Syuntaro ; Kiwada, Hiroshi</creatorcontrib><description>We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, subsequently leading to substantial complement activation and complement-receptor mediated uptake of the second dose by hepatic Kupffer cells. In this study we found, by using a single-pass liver perfusion technique, that the first dose does not increase the intrinsic phagocytic activity of the Kupffer cells. It was also found that only serum obtained from rats that had received a first dose is able to enhance the hepatic uptake of test dose. The conditioned-serum-dependent hepatic uptake was completely abolished by pre-treatment of the serum at 56 °C for 30 min, which inhibits the complement activity. Conclusively, our results strongly support our earlier proposal that complement activation caused by anti-PEG IgM elicited by the first dose is a major cause of the initiation of the accelerated blood clearance of a subsequent dose PEGylated liposome in the ABC phenomenon.</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2007.11.009</identifier><identifier>PMID: 18160170</identifier><identifier>CODEN: JCREEC</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Accelerated blood clearance (ABC) phenomenon ; Animals ; Biological and medical sciences ; Complement system ; General pharmacology ; Liposomes ; Liver - cytology ; Liver - drug effects ; Liver - metabolism ; Liver perfusion ; Macrophages - drug effects ; Macrophages - metabolism ; Male ; Medical sciences ; Metabolic Clearance Rate - drug effects ; Metabolic Clearance Rate - physiology ; PEGylated liposome ; Phagocytes - drug effects ; Phagocytes - metabolism ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polyethylene glycol (PEG) ; Polyethylene Glycols - administration &amp; dosage ; Polyethylene Glycols - pharmacokinetics ; Rats ; Rats, Wistar</subject><ispartof>Journal of controlled release, 2008-03, Vol.126 (2), p.162-165</ispartof><rights>2007 Elsevier B.V.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-f6d6937f5ef8f4bff81fe3b43c6aee7c96b91b4c9531897e06bae5ec3df283293</citedby><cites>FETCH-LOGICAL-c490t-f6d6937f5ef8f4bff81fe3b43c6aee7c96b91b4c9531897e06bae5ec3df283293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168365907006323$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20086029$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18160170$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishida, Tatsuhiro</creatorcontrib><creatorcontrib>Kashima, Syuntaro</creatorcontrib><creatorcontrib>Kiwada, Hiroshi</creatorcontrib><title>The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, subsequently leading to substantial complement activation and complement-receptor mediated uptake of the second dose by hepatic Kupffer cells. In this study we found, by using a single-pass liver perfusion technique, that the first dose does not increase the intrinsic phagocytic activity of the Kupffer cells. It was also found that only serum obtained from rats that had received a first dose is able to enhance the hepatic uptake of test dose. The conditioned-serum-dependent hepatic uptake was completely abolished by pre-treatment of the serum at 56 °C for 30 min, which inhibits the complement activity. Conclusively, our results strongly support our earlier proposal that complement activation caused by anti-PEG IgM elicited by the first dose is a major cause of the initiation of the accelerated blood clearance of a subsequent dose PEGylated liposome in the ABC phenomenon.</description><subject>Accelerated blood clearance (ABC) phenomenon</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Complement system</subject><subject>General pharmacology</subject><subject>Liposomes</subject><subject>Liver - cytology</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Liver perfusion</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic Clearance Rate - drug effects</subject><subject>Metabolic Clearance Rate - physiology</subject><subject>PEGylated liposome</subject><subject>Phagocytes - drug effects</subject><subject>Phagocytes - metabolism</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyethylene glycol (PEG)</subject><subject>Polyethylene Glycols - administration &amp; dosage</subject><subject>Polyethylene Glycols - pharmacokinetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu3CAYhFHVqNmkfYRWXFqlB7tgbGxOVbJK00iR2kN6Rhj_NKyw2QK70j5FXzl412qPOSAk-Gbgn0HoPSUlJZR_2ZQb7acArqwIaUtKS0LEK7SiXcuKWojmNVplrisYb8Q5uohxQwhpWN2-Qee0o5zQlqzQ38cnwNkoBdvvkvUT9gZvn9Rvrw_Jaqx0snubDvOxs3sIeFQ6-JmAiJPHKeuV1uAgqAQD7p33A9YOVFCTBnx1fbP-nB1h8mNeR_-ft3cHd6Sd3fqYLyK2E84G8S06M8pFeLfsl-jXt9vH9ffi4cfd_fr6odC1IKkwfOCCtaYB05m6N6ajBlhfM80VQKsF7wXtay0aRjvRAuG9ggY0G0zVsUqwS_Tp5LsN_s8OYpKjjXkKpybwuyhbUokqx_UiWFHCGWFtBpsTmOOJMYCR22BHFQ6SEjlXJjdyqUzOlUlKZa4s6z4sD-z6EYb_qqWjDHxcABW1cmbO1cZ_XPbqODmO9PXEQc5tbyHIqC3kDgYbQCc5ePvCV54BTrO59g</recordid><startdate>20080303</startdate><enddate>20080303</enddate><creator>Ishida, Tatsuhiro</creator><creator>Kashima, Syuntaro</creator><creator>Kiwada, Hiroshi</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20080303</creationdate><title>The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats</title><author>Ishida, Tatsuhiro ; Kashima, Syuntaro ; Kiwada, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-f6d6937f5ef8f4bff81fe3b43c6aee7c96b91b4c9531897e06bae5ec3df283293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Accelerated blood clearance (ABC) phenomenon</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Complement system</topic><topic>General pharmacology</topic><topic>Liposomes</topic><topic>Liver - cytology</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Liver perfusion</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic Clearance Rate - drug effects</topic><topic>Metabolic Clearance Rate - physiology</topic><topic>PEGylated liposome</topic><topic>Phagocytes - drug effects</topic><topic>Phagocytes - metabolism</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyethylene glycol (PEG)</topic><topic>Polyethylene Glycols - administration &amp; dosage</topic><topic>Polyethylene Glycols - pharmacokinetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishida, Tatsuhiro</creatorcontrib><creatorcontrib>Kashima, Syuntaro</creatorcontrib><creatorcontrib>Kiwada, Hiroshi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishida, Tatsuhiro</au><au>Kashima, Syuntaro</au><au>Kiwada, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2008-03-03</date><risdate>2008</risdate><volume>126</volume><issue>2</issue><spage>162</spage><epage>165</epage><pages>162-165</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><coden>JCREEC</coden><abstract>We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, subsequently leading to substantial complement activation and complement-receptor mediated uptake of the second dose by hepatic Kupffer cells. In this study we found, by using a single-pass liver perfusion technique, that the first dose does not increase the intrinsic phagocytic activity of the Kupffer cells. It was also found that only serum obtained from rats that had received a first dose is able to enhance the hepatic uptake of test dose. The conditioned-serum-dependent hepatic uptake was completely abolished by pre-treatment of the serum at 56 °C for 30 min, which inhibits the complement activity. Conclusively, our results strongly support our earlier proposal that complement activation caused by anti-PEG IgM elicited by the first dose is a major cause of the initiation of the accelerated blood clearance of a subsequent dose PEGylated liposome in the ABC phenomenon.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>18160170</pmid><doi>10.1016/j.jconrel.2007.11.009</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2008-03, Vol.126 (2), p.162-165
issn 0168-3659
1873-4995
language eng
recordid cdi_proquest_miscellaneous_70292053
source MEDLINE; Elsevier ScienceDirect Journals
subjects Accelerated blood clearance (ABC) phenomenon
Animals
Biological and medical sciences
Complement system
General pharmacology
Liposomes
Liver - cytology
Liver - drug effects
Liver - metabolism
Liver perfusion
Macrophages - drug effects
Macrophages - metabolism
Male
Medical sciences
Metabolic Clearance Rate - drug effects
Metabolic Clearance Rate - physiology
PEGylated liposome
Phagocytes - drug effects
Phagocytes - metabolism
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polyethylene glycol (PEG)
Polyethylene Glycols - administration & dosage
Polyethylene Glycols - pharmacokinetics
Rats
Rats, Wistar
title The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A36%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20contribution%20of%20phagocytic%20activity%20of%20liver%20macrophages%20to%20the%20accelerated%20blood%20clearance%20(ABC)%20phenomenon%20of%20PEGylated%20liposomes%20in%20rats&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Ishida,%20Tatsuhiro&rft.date=2008-03-03&rft.volume=126&rft.issue=2&rft.spage=162&rft.epage=165&rft.pages=162-165&rft.issn=0168-3659&rft.eissn=1873-4995&rft.coden=JCREEC&rft_id=info:doi/10.1016/j.jconrel.2007.11.009&rft_dat=%3Cproquest_cross%3E70292053%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21063037&rft_id=info:pmid/18160170&rft_els_id=S0168365907006323&rfr_iscdi=true